Neurogene Inc. (LS:A3EX79) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · May 8, 2017 – Dec 18, 2023 · Past |
| Julian Baker Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past) | Director · May 8, 2017 – Dec 18, 2023 · Past |
| Martin Babler Other companies: MapLight Therapeutics, Inc. (Member of the Audit Committee · Since at least Jun 23, 2026); Alumis Inc. (President, Chief Executive Officer and Chairman of the Board · Since at least Jun 27, 2024); 89bio Inc (Director · Since at least Apr 13, 2024); Prelude Therapeutics Incorporated (Director · Since at least Jul 19, 2021); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Principia Biopharma Inc (President, CEO, Director · Sep 13, 2018 – Sep 28, 2020 · Past); ZS Pharma Inc (Director · Mar 19, 2015 – Dec 17, 2015 · Past) | Director · Sep 8, 2020 – Jun 8, 2023 · Past |
| Kelvin Neu Other companies: Theravance Biopharma, Inc. (MD, PhD · Since at least Nov 5, 2026); Zymeworks Inc. (Director · Since at least Mar 16, 2020); Prelude Therapeutics Incorporated (Director · Sep 24, 2020 – Sep 24, 2020 · Past); IGM Biosciences Inc (Director · Sep 17, 2019 – Sep 17, 2019 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Mar 10, 2014 · Past) | Director · Mar 23, 2017 – Mar 23, 2017 · Past |
| Sean P. Nolan Other companies: Taysha Gene Therapies, Inc. (Chief Executive Officer and Board Chairman · Since at least Sep 23, 2020); Ventas, Inc. (Director · Since at least Jul 26, 2019); Social Capital Suvretta Holdings Corp II (Director · Sep 24, 2021 – Sep 24, 2021 · Past); AveXis Inc (President & CEO, Director · Feb 10, 2016 – May 15, 2018 · Past); InterMune Inc (EVP & CBO · Feb 11, 2013 – Sep 29, 2014 · Past) | Director · Feb 16, 2015 – May 5, 2020 · Past |
| Erin Lavelle Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Climb Bio, Inc. (COO & CFO · Aug 9, 2021 – Oct 31, 2022 · Past); Alder BioPharmaceuticals Inc (Chief Operating Officer · Apr 16, 2018 – Oct 22, 2019 · Past) | Director · May 12, 2022 – Jun 8, 2023 · Past |
| Keith Woods Other companies: Scholar Rock Holding Corporation (Chief Operating Officer · Since at least Apr 27, 2025); TScan Therapeutics, Inc. (Director · Since at least Dec 6, 2023); X4 Pharmaceuticals, Inc. (Director · Since at least Oct 16, 2023); Rocket Pharmaceuticals, Inc. (Director · Dec 7, 2023 – Jun 13, 2024 · Past) | Director · Since at least Jun 12, 2025 |
| Lewis T. Rusty Williams Other companies: Protagonist Therapeutics, Inc. (Director, Co-Founder, Chairman · Since at least Jun 7, 2017); Arcellx Inc (Director · Feb 3, 2022 – Feb 8, 2022 · Past); Five Prime Therapeutics Inc (Director · Sep 17, 2013 – Sep 1, 2019 · Past); Beckman Coulter Inc (Director · Oct 23, 2009 – Jun 30, 2011 · Past) | Director · Aug 8, 2019 – May 11, 2021 · Past |
| Christine Mikail Cvijic Other companies: Sio Gene Therapies Inc (Chief Admin Officer and GC · Jun 10, 2015 – Apr 29, 2016 · Past); NPS Pharmaceuticals Inc (SVP, Legal Affairs & GC · Mar 3, 2014 – Feb 21, 2015 · Past); Dendreon Corp (EVP, Corp Dev, Gen Cnsl/Scrtry · Feb 29, 2012 – Feb 10, 2014 · Past) | President and CFO, Director · Since at least Dec 18, 2023 |
| Gary L. Bridger Other companies: X4 Pharmaceuticals, Inc. (Board Member · Since at least Mar 13, 2019); Xenon Pharmaceuticals Inc. (EVP, Research & Development · Nov 4, 2014 – Nov 21, 2014 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 31, 2015 · Past) | Director · Mar 6, 2014 – May 7, 2018 · Past |
| Jonathan G Drachman Other companies: Harpoon Therapeutics Inc (Director · Feb 7, 2019 – Mar 8, 2024 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Nov 10, 2021 · Past); Seagen Inc (CMO & EVP, R & D · Oct 1, 2013 – Mar 20, 2018 · Past) | President and CEO, Director · Aug 8, 2019 – Aug 2, 2022 · Past |
| Robert A. Baffi Other companies: Mosaic ImmunoEngineering Inc (Director · Since at least Jul 15, 2021); Humanigen Inc (Director · Nov 25, 2014 – Jul 10, 2015 · Past); BioMarin Pharmaceutical Inc. (President, Global Mfg/Tech Ops · Apr 10, 2013 – Mar 20, 2020 · Past) | Director · Since at least Dec 18, 2023 |
| Rohan Palekar Other companies: 89bio Inc (Chief Executive Officer, Director · Since at least Nov 8, 2019); Avanir Pharmaceuticals Inc (SVP & Chief Commercial Officer · Apr 3, 2012 – Nov 28, 2014 · Past); Medivation Inc (Chief Commercial Officer · Jan 14, 2008 – Apr 20, 2011 · Past) | Director · Since at least Mar 2, 2022 |
| Sarah B. Noonberg Other companies: Metagenomi Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 8, 2024); Marinus Pharmaceuticals Inc (Director · May 16, 2023 – Jun 18, 2024 · Past); Protagonist Therapeutics, Inc. (Director · Dec 12, 2017 – Jan 16, 2023 · Past) | Director · Since at least Aug 8, 2019 |
| Kamran Alam Other companies: Taysha Gene Therapies, Inc. (Chief Financial Officer · Since at least Sep 23, 2020); Rocket Pharmaceuticals, Inc. (SVP - Finance & PFO · Oct 28, 2019 – Feb 6, 2020 · Past) | CFO, Vice President Finance · Mar 9, 2018 – Aug 7, 2018 · Past |
| Todd Simpson Other companies: Xencor, Inc. (Director · Since at least Mar 13, 2025); Seagen Inc (Chief Financial Officer · Jan 31, 2006 – Dec 14, 2023 · Past) | Director · Mar 6, 2014 – Jun 8, 2023 · Past |
| Christina Shafer Other companies: Marinus Pharmaceuticals Inc (CHIEF COMMERCIAL OFFICER · Jun 15, 2022 – Feb 7, 2025 · Past) | Chief Commercial Officer · Since at least Apr 20, 2026 |
| Cory S Freedland Other companies: Jiya Acquisition Corp (Chief Investment Officer, Director · Nov 18, 2020 – Nov 18, 2020 · Past) | Director · Since at least Dec 18, 2023 |
| Daniel J Levitt Other companies: Sorrento Therapeutics, Inc. (Director · Jan 30, 2014 – Jan 30, 2014 · Past) | Director · Mar 6, 2014 – May 14, 2018 · Past |
| Julie Jordan Other companies: Q32 Bio Inc. (Chief Medical Officer · Mar 7, 2023 – Aug 3, 2023 · Past) | Chief Medical Officer · Since at least Jan 16, 2024 |
| Meta Cantey Boyd Other companies: Kiniksa Pharmaceuticals International, plc (Director · Oct 4, 2024 – Oct 4, 2024 · Past) | Director · Aug 8, 2019 – Aug 8, 2019 · Past |
| Rachel McMinn Other companies: Intercept Pharmaceuticals Inc (Chief Strategy Officer · Apr 30, 2014 – Oct 2, 2017 · Past) | Founder and Chief Executive Officer · Since at least Dec 18, 2023 |
| Robert Ho Other companies: Third Harmonic Bio Inc. (Chief Financial Officer · Sep 14, 2022 – Mar 6, 2023 · Past) | Chief Financial Officer · Mar 16, 2020 – Feb 1, 2022 · Past |
| Shelley McCloskey Other companies: Xenon Pharmaceuticals Inc. (Executive Vice President, Human Resources · Since at least Nov 5, 2026) | VP, HR and Administration · Dec 14, 2015 – Aug 7, 2018 · Past |
| Abigail Jenkins | Chief Commercial Officer · Jun 6, 2016 – Mar 9, 2018 · Past |
| Andrew Mulberg | Senior Vice President, Regulatory Affairs, Quality Assurance, and Quality Control · Since at least Nov 4, 2026 |
| Arvind Sreedharan | Senior Vice President, Business Operations · Since at least Nov 5, 2026 |
| Carl Walkey | Senior Vice President · Jan 30, 2021 – Aug 2, 2022 · Past |
| Christine Mikail | President and Chief Financial Officer · Since at least Apr 20, 2026 |
| Christy Shafer | Chief Commercial Officer · Since at least Apr 20, 2026 |
| David Chilton Mitchell | VP Global Regulatory & Quality · Aug 11, 2015 – Mar 8, 2017 · Past |
| David Main | President and CEO, Director · Mar 6, 2014 – Aug 7, 2018 · Past |
| Donna M. Cochener | Senior Vice President and General Counsel · Since at least Mar 14, 2022 |
| Erin M Lavelle | Director · Jun 1, 2020 – May 11, 2021 · Past |
| Holly Vance | General Counsel · Oct 19, 2020 – Aug 3, 2021 · Past |
| Lina Li | Executive Director, Investor Relations · Since at least Sep 8, 2026 |
| Mike Devine | Executive Director, Corporate Communications · Since at least Sep 8, 2026 |
| Priti Patel | Chief Medical Officer · Apr 30, 2021 – Feb 1, 2023 · Past |
| Ricardo Jimenez | Senior Vice President, Technical Operations · Since at least Nov 5, 2026 |
| Robert Keith Woods | Director · Since at least Dec 18, 2023 |
| Sean Michael Smith | Interim CFO, Prin Acct Off · Mar 2, 2022 – Aug 10, 2023 · Past |
| Stuart Cobb | Chief Scientific Officer · Since at least Dec 18, 2023 |